Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders-Reference-Cited by-同舟云学术

Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders

Published:2014-06-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Mahapatra Jataveda¹,Quraishi Seema N²,David Anthony³,Sampson Stephanie⁴,Adams Clive E⁴

Affiliation:

1. Metro South Health Services; Logan Hospital; Brisbane Queensland Australia 4113

2. SQ Therapy; 1 Harley street London UK W1G 9QD

3. Institute of Psychiatry; De Crespigny Park PO Box 68 London UK SE5 8AF

4. The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health University of Nottingham Innovation Park, Jubilee Campus Nottingham UK NG7 2TU

Publisher

Wiley

Subject

Pharmacology (medical)

Reference207 articles.

1. High dose neuroleptic treatment of chronic schizophrenic inpatients;Cookson;Research Communications in Psychology, Psychiatry and Behaviour,1983

2. The effects of a 50% reduction of cis(Z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime;Cookson;International Clinical Psychopharmacology,1987

3. Depot antipsychotics in schizophrenic patients: a comparison between haloperidol decanoate and flupenthixol decanoate;Eberhard;International Clinical Psychopharmacology,1986

4. Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison;Eberhard;Acta Psychiatria Scandinavica,1986

5. Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl);Eufe;Nervenarzt,1979

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antipsychotic-induced bone loss: the role of dopamine, serotonin and adrenergic receptor signalling;Frontiers in Cell and Developmental Biology;2023-05-25

2. G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders;Signal Transduction and Targeted Therapy;2023-05-03

3. Two Neuroanatomical Signatures in Schizophrenia: Expression Strengths Over the First 2 Years of Treatment and Their Relationships to Neurodevelopmental Compromise and Antipsychotic Treatment;Schizophrenia Bulletin;2023-04-12

4. Antipsychotic treatment effects and structural MRI brain changes in schizophrenia;Psychological Medicine;2021-09-23

5. Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate;South African Journal of Psychiatry;2021-01-11